| Last update: 12.09.2025 15:25:00 |
Early-Bird-Symposium Erbe Swiss AG: Die Zukunft ist unter Wasser | ||||
| 07:45 - 08:15 | Early-Bird-Symposium Erbe Swiss AG: Die Zukunft ist unter Wasser Chair: Peter Bauerfeind, Luzern | 11.09.25 17:02 | ||
Hepatology Hot Topics 2025 | ||||
| 08:30 - 10:00 | Hepatology Hot Topics 2025 Chair: Herr David Semela, St. Gallen / Annalisa Berzigotti, Bern | |||
| 08:30 - 08:52 | Present and future of immunotherapies in the management of HCC Josep M. Llovet, Barcelona | 12.09.25 08:21 | ||
| 08:52 - 09:14 | Emerging therapies for cholestatic liver diseases Andreas Kremer, Zürich | 12.09.25 08:21 | ||
| 09:14 - 09:36 | State of the art: transjugular intrahepatic portosystemic shunt (TIPS) Virginia Hernández-Gea, Barcelona | 12.09.25 08:23 | ||
| 09:36 - 10:00 | Viral Hepatitis: update 2025 Beat Müllhaupt, Zürich | 12.09.25 08:22 | ||
Lunch symposium Eli Lilly: From Evidence to Everyday Practice: Long-Term Outcomes with Omvoh® in IBD | ||||
| 12:15 - 12:45 | Lunch symposium Eli Lilly: From Evidence to Everyday Practice: Long-Term Outcomes with Omvoh® in IBD Chair: Gerhard Rogler, Zürich / Frank Seibold, Bern | 12.09.25 12:01 | ||
Lunch symposium Pfizer: Velsipity in Practice: Ask the Experts | ||||
| 12:50 - 13:20 | Lunch symposium Pfizer: Velsipity in Practice: Ask the Experts Chair: Luc Biedermann, Zürich / Thomas Greuter, Lugano / Robert Hoepner, Bern | 11.09.25 11:13 | ||
Hepatology oral presentations II | ||||
| 13:30 - 15:00 | Hepatology oral presentations II Chair: Nicolas Goossens, Genève / Anja Lachenmayer, Bern | |||
| 13:30 - 13:55 | The skin-neuron-axis in cholestatic pruritus Andreas Kremer, Zürich | 12.09.25 11:25 | ||
| 14:00 - 14:10 | Validation of Lille Model at day 4 in patients with severe alcoholic hepatitis Nicolas Conquet, Geneva | 12.09.25 09:29 | ||
| 14:10 - 14:20 | Monocyte Distribution Width as a Novel Biomarker for Assessing Disease Severity in Liver Cirrhosis Lukas Jutzi, Basel | 12.09.25 07:32 | ||
| 14:20 - 14:30 | MAIT cell depletion and dysfunction in patients with portal hypertension undergoing TIPSS Josias Mürle, Basel | 12.09.25 09:16 | ||
| 14:30 - 14:40 | Impact of Loss of PCSK9 Expression in Hepatocytes Ainhoa Asensio Aldave, Bern | 12.09.25 08:13 | ||
| 14:40 - 14:50 | A HEV ORF2 protein-mediated mechanism of hepatitis E-associated kidney disease Anne-Laure Leblond, Zurich | |||
| 14:50 - 15:00 | Post-Banding Ulcer Bleeding After Endoscopic Ligation: Incidence, Risk Factors, and Outcomes in Patients with Cirrhosis Maria de Brito Nunes, Bern | 12.09.25 09:14 | ||
Abdominal Sonography Course (SGUM: 2 Credits) | ||||
| 15:00 - 17:00 | Abdominal Sonography Course (SGUM: 2 Credits) Chair: Isabelle Panne, Basel / Pamela Meyer-Herbon, St. Gallen / Irina Bergamin, St. Gallen | 12.09.25 12:49 | ||